| Similar Articles |
|---|
 |
The Motley Fool
February 26, 2007
Rich Smith |
Foolish Forecast: Cryo-Cell Defrosting The cord-blood storage specialist will report its fourth-quarter and full-year financial news shortly. Investors, here is what you can expect to see.   |
The Motley Fool
March 5, 2007
Rich Smith |
ViaCell Not Doing Well The company's biotech half continues to sap revenue from the moneymaking side. Investors, take note. |
The Motley Fool
April 18, 2005
Rich Smith |
U.S. Government Out for Blood Two companies await as the Institute of Medicine advocates improvements in cord blood banking. Newly public ViaCell has been plummeting along with rival Cryo-Cell, down roughly 40% over the past three months. |
The Motley Fool
April 27, 2007
Rich Smith |
Foolish Forecast: ViaCell Doing Swell? The cord blood specialist is set to release its first-quarter 2007 earnings. Investors, here is what you can expect to see. |
The Motley Fool
November 30, 2004
Rich Smith |
Breaking Rules and Saving Lives Cord blood offers an ethical means of using stem cells to heal illness. While two top companies in the field are private, over the counter traded Cryo-Cell lost as much money as it collected in revenues last year. |
The Motley Fool
August 2, 2006
Rich Smith |
Foolish Forecast: Anemic ViaCell The cord blood storage specialist is due to report its second quarter 2006 numbers tomorrow. Investors, take note. |
The Motley Fool
February 23, 2007
Rich Smith |
Foolish Forecast: ViaCell Doing Well? The cord blood specialist is set to report its fourth-quarter and full-year 2006 numbers shortly. Investors, here is what you can expect to see. |
The Motley Fool
August 13, 2007
Rich Smith |
ViaCell Sees the Light Despite rising sales at its trademark ViaCord umbilical cord blood storage service, and gross margin from this service rising in tandem, the firm's operating and net results remain mired in thick red ink. Investors, take note. |
The Motley Fool
August 8, 2006
Rich Smith |
Second Opinion on ViaCell The prognosis isn't good. Is there still hope for ViaCell? Of course! Hope springs eternal. If ViaCell can just tighten its purse strings, investors may yet find a way to save blood and make money. |
The Motley Fool
May 1, 2007
Rich Smith |
The Losses Swell at ViaCell Given that ViaCell has been ramping up its sales and marketing spending for about a year, it's about time ViaCell's stock start showing some results from this "investment." |
